Applied Molecular Transport Inc.

NasdaqCM:AMTI Voorraadrapport

Marktkapitalisatie: US$10.9m

Applied Molecular Transport Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Applied Molecular Transport's earnings have been declining at an average annual rate of -25.6%, while the Biotechs industry saw earnings growing at 17.4% annually.

Belangrijke informatie

-25.6%

Groei van de winst

13.3%

Groei van de winst per aandeel

Biotechs Groei van de industrie17.0%
Inkomstengroein/a
Rendement op eigen vermogen-460.5%
Nettomargen/a
Laatste winstupdate30 Sep 2023

Recente prestatie-updates uit het verleden

Geen updates

Recent updates

Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Mar 07
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Nov 13
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Applied Molecular Transport GAAP EPS of -$0.93

Aug 04

Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Jul 27
Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data

Jul 05

Applied Molecular: Interesting Drug Delivery Approach For The GI Tract

May 03

We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Apr 28
We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Jan 08
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Aug 29
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Apr 05
Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Feb 11
Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Dec 21
Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Applied Molecular Transport reports Q3 results

Nov 12

Opbrengsten en kosten

Hoe Applied Molecular Transport geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqCM:AMTI Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 230-7529-11
30 Jun 230-93307
31 Mar 230-1123227
31 Dec 220-1263745
30 Sep 220-1343764
30 Jun 220-1353764
31 Mar 220-1223558
31 Dec 210-1002941
30 Sep 210-892558
30 Jun 210-802027
31 Mar 210-721623
31 Dec 200-671354
30 Sep 200-551030
30 Jun 200-46746
31 Mar 200-38633
31 Dec 190-28424

Kwaliteitswinsten: AMTI is currently unprofitable.

Groeiende winstmarge: AMTI is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: AMTI is unprofitable, and losses have increased over the past 5 years at a rate of 25.6% per year.

Versnelling van de groei: Unable to compare AMTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: AMTI is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-42.7%).


Rendement op eigen vermogen

Hoge ROE: AMTI has a negative Return on Equity (-460.5%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden